Diffuse panbronchiolitis

Poletti V., Casoni G., Chilosi M., Zompatori M.

Source: Eur Respir J 2006 Oct 01;28(4):862-871
Journal Issue: October
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Poletti V., Casoni G., Chilosi M., Zompatori M.. Diffuse panbronchiolitis. Eur Respir J 2006 Oct 01;28(4):862-871

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Diffuse panbronchiolitis
Source: Eur Respir J 2008; 32: 237-238
Year: 2008


Association of Gc-globulin variation with susceptibility to COPD and diffuse panbronchiolitis
Source: Eur Respir J 2001; 18: 753-757
Year: 2001



Diffuse panbronchiolitis and mimickers of bronchiolitis
Source: Annual Congress 2004 - PG14 - Bronchiolitis in adults
Year: 2004

Desquamative interstitial pneumonia - DIP
Source: Respipedia Article
Year: 2017

Rare interstitial lung diseases (LAM, LHC, alveolar proteinosis, eosinophilic pneumonias)
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2018

Rare interstitial lung diseases (LAM, LHC, alveolar proteinosis, eosinophilic pneumonias)
Source: ERS Course 2016
Year: 2016



Rare interstitial lung diseases (LAM, LHC, alveolar proteinosis, eosinophilic pneumonias)
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2019


Rare interstitial lung diseases (LAM, LHC, alveolar proteinosis, eosinophilic pneumonias)
Source: ERS Courses: Interstitial Lung Diseases
Year: 2019


Prevalence of nontuberculous mycobacteria in diffuse panbronchiolitis
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012


Long-term macrolides in diffuse interstitial lung diseases
Source: Eur Respir Rev, 26 (146) 170082; 10.1183/16000617.0082-2017
Year: 2017



CD8+ T-cell alveolitis in familial pulmonary alveolar microlithiasis
Source: Eur Respir J 2007; 30: 165-171
Year: 2007



Diffuse idiopathic pulmonary neuroendocrine hyperplasia, chronic eosinophilic pneumonia, and asthma
Source: Eur Respir J 2009; 34: 1489-1492
Year: 2009


Effect of azithromycin-predominant combined therapy on patients with diffuse panbronchiolitis
Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Year: 2009


Interstitial lung disease (ILD) in association with polymyositis-dermatomyositis (PM/DM) with predominant lymphocytic alveolitis and anti-Jo-1-antibodies
Source: Eur Respir J 2002; 20: Suppl. 38, 586s
Year: 2002

Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis
Source: Eur Respir J 2001; 18: 43S-55S
Year: 2001



Pulmonary manifestations of immunoglobulin G4-related sclerosing disease
Source: Eur Respir J 2012; 39: 180-186
Year: 2012



Pulmonary manifestations of immunoglobulin G4-related sclerosing disease
Source: Eur Respir J 2011; 39: 180-186
Year: 2012



Histopathology of bronchiectasis
Source: Eur Respir Mon 2011; 52: 22-31
Year: 2011


Nonspecific interstitial pneumonia - NSIP
Source: Respipedia Article
Year: 2015

Centrilobular fibrosis (CLF): a distinct histological pattern in systemic sclerosis
Source: Annual Congress 2006 - Pulmonary fibrosis: pathophysiology and therapeutic approaches
Year: 2006